These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 17916909

  • 1. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R.
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [Abstract] [Full Text] [Related]

  • 2. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [Abstract] [Full Text] [Related]

  • 3. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.
    Cancer Res; 2002 Jun 01; 62(11):3063-9. PubMed ID: 12036915
    [Abstract] [Full Text] [Related]

  • 4. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Singh RP, Tyagi A, Sharma G, Mohan S, Agarwal R.
    Clin Cancer Res; 2008 Jan 01; 14(1):300-8. PubMed ID: 18172282
    [Abstract] [Full Text] [Related]

  • 5. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 6. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.
    Oncogene; 2003 Nov 13; 22(51):8271-82. PubMed ID: 14614451
    [Abstract] [Full Text] [Related]

  • 7. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R.
    Cancer Res; 2004 Sep 01; 64(17):6349-56. PubMed ID: 15342425
    [Abstract] [Full Text] [Related]

  • 8. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
    Deep G, Oberlies NH, Kroll DJ, Agarwal R.
    Carcinogenesis; 2007 Jul 01; 28(7):1533-42. PubMed ID: 17389612
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer chemoprevention by silibinin: bench to bedside.
    Singh RP, Agarwal R.
    Mol Carcinog; 2006 Jun 01; 45(6):436-42. PubMed ID: 16637061
    [Abstract] [Full Text] [Related]

  • 10. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
    Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R.
    Carcinogenesis; 2004 Aug 01; 25(8):1459-65. PubMed ID: 15033902
    [Abstract] [Full Text] [Related]

  • 11. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R.
    Oncogene; 2006 Feb 16; 25(7):1053-69. PubMed ID: 16205633
    [Abstract] [Full Text] [Related]

  • 12. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov 16; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 13. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
    Singh RP, Mallikarjuna GU, Sharma G, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R.
    Clin Cancer Res; 2004 Dec 15; 10(24):8641-7. PubMed ID: 15623648
    [Abstract] [Full Text] [Related]

  • 14. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
    Zi X, Zhang J, Agarwal R, Pollak M.
    Cancer Res; 2000 Oct 15; 60(20):5617-20. PubMed ID: 11059749
    [Abstract] [Full Text] [Related]

  • 15. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
    Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L, Liu D.
    Carcinogenesis; 2004 Aug 15; 25(8):1403-8. PubMed ID: 15016658
    [Abstract] [Full Text] [Related]

  • 16. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV.
    Clin Cancer Res; 2006 Nov 15; 12(22):6836-43. PubMed ID: 17121905
    [Abstract] [Full Text] [Related]

  • 17. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
    Panopoulou E, Murphy C, Rasmussen H, Bagli E, Rofstad EK, Fotsis T.
    Cancer Res; 2005 Mar 01; 65(5):1877-86. PubMed ID: 15753386
    [Abstract] [Full Text] [Related]

  • 18. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 Oct 01; 24(10):1665-70. PubMed ID: 12896904
    [Abstract] [Full Text] [Related]

  • 19. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA.
    Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369
    [Abstract] [Full Text] [Related]

  • 20. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL, Capodice JL, Desai M, Buttyan R, Katz AE.
    Clin Cancer Res; 2004 Aug 01; 10(15):5282-92. PubMed ID: 15297432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.